Track Cellectar Biosciences Inc (CLRB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Cellectar Biosciences Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Cellectar Biosciences has a consensus price target of $ Q. What is the current price for Cellectar Biosciences (CLRB)?. A. The stock. Based on short-term price targets offered by three analysts, the average price target for Cellectar Biosciences, Inc. comes to $ The forecasts range from. CLRB / Cellectar Biosciences, Inc. (NasdaqCM) - Forecast, Price Target, Estimates, Predictions.
Tomorrow's movement Prediction of Cellectar Biosciences, Inc. CLRB appears strongly Bearish. This stock started falling as soon as it opened and never recovered. Cellectar Biosciences Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CLRB updated stock price target summary. View Cellectar Biosciences, Inc. CLRB stock quote prices, financial information, real-time forecasts, and company news from CNN. Cellectar Biosciences Inc Price (CLRB) Daily Price Prediction Charts. Assess the Cellectar Biosciences stock price estimates. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Bid Price and Ask Price. The bid & ask refers to the price that an. Cellectar Biosciences reported an EPS of -$ in its last earnings report, expectations of -$ Following the earnings report the stock price went up 8. Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for. CLRB Share Price Expert Analysis, Cellectar Biosciences Inc. Buy or Sell Recommendations, Forecasts, Comparison and Market Data. The current price of CLRB is USD — it has decreased by −% in the past 24 hours. Watch Cellectar Biosciences, Inc. stock price performance more closely. Discover Cellectar Biosciences' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers.
Analyst Price Targets ; ; Average ; Current ; High. According to analysts, CLRB price target is USD with a max estimate of USD and a min estimate of USD. Cellectar Biosciences stock price target cut to $ from $ at Maxim Group. Nov. 8, at a.m. ET by Tomi Kilgore. Cellectar Biosciences started. The 2 analysts with month price forecasts for CLRB stock have an average target of 20, with a low estimate of 12 and a high estimate of The average. According to analysts, Cellectar Biosciences's stock has a predicted upside of % based on their month stock forecasts. Do. (NASDAQ: CLRB) Cellectar Biosciences stock price per share is $ today (as of Aug 7, ). What is Cellectar Biosciences's Market Cap. The average Cellectar Biosciences stock price prediction forecasts a potential upside of % from the current CLRB share price of $ Cellectar BioSciences stock would need to gain 23,% to reach $ According to our Cellectar BioSciences stock forecast, the price of Cellectar. Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of.
Cellectar Biosciences stock price forecast: $12; Market Cap: M, Enterprise value: N/A, P/E: , PEG ratio: , EPS: , Revenue: N/A. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. FAQ ; What Is the Cellectar Biosciences (CLRB) Stock Price Today? The Cellectar Biosciences stock price today is ; What Stock Exchange Does Cellectar. The 2 analysts with month price forecasts for CLRB stock have an average target of 20, with a low estimate of 12 and a high estimate of The average. View Cellectar BioSciences (CLRB) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo.
Biotech boom ahead in 2024, top Jefferies analyst predicts on heels of Bristol Meyers-Karuna deal
Yes, Indians can invest in the Cellectar Biosciences Inc (CLRB) from India. With INDmoney, you can buy Cellectar Biosciences Inc at 0 brokerage. The step-by-. It currently has a Growth Score of C. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a.